(Q36303988)

13 August 2017

1 reference

title

Ventricular arrhythmia in congestive heart failure (English)

1 reference

Cardiology and cardiovascular medicine

13 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

17 October 2022

congestive heart failure

1 reference

P. J. Podrid

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626494

17 October 2022

R. I. Fogel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626494

17 October 2022

T. T. Fuchs

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1626494

17 October 2022

language of work or name

English

0 references

publication date

1 June 1992

1 reference

13 August 2017

4 June 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1626494

full work available at URL

17 October 2022

https://api.elsevier.com/content/article/PII:0002914992912575?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

https://api.elsevier.com/content/article/PII:0002914992912575?httpAccept=text/plain

17 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

American Journal of Cardiology

17 October 2022

published in

1 reference

13 August 2017

volume

69

1 reference

13 August 2017

issue

18

1 reference

13 August 2017

page(s)

82G-95G; discussion 95G-96G

1 reference

Risk factors for sudden death after acute myocardial infarction: two-year follow-up

13 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

17 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

17 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients

17 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

17 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Sudden death in idiopathic cardiomyopathy

17 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy

17 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure

17 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Ventricular arrhythmias in idiopathic dilated cardiomyopathy.

17 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography

17 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy

17 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis

17 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Factors influencing the one-year mortality of dilated cardiomyopathy.

17 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Dilated cardiomyopathy: functional status, hemodynamics, arrhythmias, and prognosis

17 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone

17 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group

17 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation

17 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Genesis of Cardiac Arrhythmias

17 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Arrhythmia in heart failure: role of mechanically induced changes in electrophysiology

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Automaticity, triggered activity, and responses to adrenergic stimulation in cat subendocardial Purkinje fibers after healing of myocardial infarction

17 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

17 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Pathophysiologic mechanisms of cardiac arrhythmias

17 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Results of sympathetic denervation in the canine heart: supersensitivity that may be arrhythmogenic

17 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy

17 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Hypokalemia from Beta2-Receptor Stimulation by Circulating Epinephrine

17 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Potassium and ventricular arrhythmias

17 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Anoxia-recovery cycle in ventricular muscle: Action potential duration, contractility and ATP content

17 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Diverse mechanisms of unexpected cardiac arrest in advanced heart failure

17 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death

17 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Programmed electrical stimulation and long-term follow-up in asymptomatic, nonsustained ventricular tachycardia

17 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Value of electrophysiologic testing in patients with nonsustained ventricular tachycardia

17 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias

17 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy

17 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Programmed electrical stimulation in patients with high-grade ventricular ectopy: electrophysiologic findings and prognosis for survival

17 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Programmed electrical stimulation to determine the need for antiarrhythmic therapy in patients with complex ventricular ectopic activity

17 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Prognostic factors in nonsustained ventricular tachycardia

17 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation

17 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure

17 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia

17 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Late potentials detected after myocardial infarction: natural history and prognostic significance

17 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography

17 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Differences between patients with ventricular tachycardia and ventricular fibrillation as assessed by signal-averaged electrocardiogram, radionuclide ventriculography and cardiac mapping

17 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias

17 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Clinical study of late potentials--comparison of late potentials in myocardial infarction, cardiomyopathy and idiopathic ventricular tachycardia

17 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Value of the signal-averaged electrocardiogram as a predictor of sudden death in myocardial infarction and dilated cardiomyopathy

17 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Comparison of frequency of late potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy with advanced congestive heart failure and their usefulness in predicting sudden death

17 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Nitrate Therapy for Congestive Heart Failure

17 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo

17 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

17 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure

17 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Occurrence of ventricular arrhythmias in patients receiving acute and chronic infusions of milrinone

17 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

17 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

17 October 2022

58

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

17 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.

17 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure

17 October 2022

61

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Effect of a Digitalis Drug on Ventricular Premature Beats

17 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Effects of acetyl-strophanthidin on left ventricular function and ventricular arrhythmias

17 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Cardiac electrophysiological actions of captopril: lack of direct antiarrhythmic effects

17 October 2022

65

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Protective effects of captopril against ischemia/reperfusion-induced ventricular arrhythmias in vitro and in vivo

17 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Captopril in heart failure. A double blind controlled trial

17 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

17 October 2022

68

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Effect of enalapril on ventricular arrhythmias in congestive heart failure

17 October 2022

69

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

17 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

17 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Congestive heart failure and arrhythmias: an overview

17 October 2022

72

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Beneficial effects of low dose amiodarone in patients with congestive cardiac failure: a placebo-controlled trial

17 October 2022

73

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Mortality in heart failure: clinical variables of prognostic value

17 October 2022

74

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function

17 October 2022

76

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Role of electrophysiologic testing in managing patients who have ventricular tachycardia unrelated to coronary artery disease

17 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Induction of ventricular tachycardia during programmed electrical stimulation: analysis of pacing methods

17 October 2022

78

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy

17 October 2022

79

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy

17 October 2022

80

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy

17 October 2022

81

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias

17 October 2022

82

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial

17 October 2022

83

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Short- and long-term therapy with tocainide for malignant ventricular tachyarrhythmias.

17 October 2022

84

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Safety and efficacy of encainide for malignant ventricular arrhythmias

17 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Analysis of ventricular arrhythmias in patients with dilated cardiomyopathy--relationship between the effects of antiarrhythmic agents and severity of myocardial lesions

17 October 2022

86

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias.

17 October 2022

87

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio

17 October 2022

88

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease

17 October 2022

89

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Predictors of the success or failure of medical therapy in patients with chronic recurrent sustained ventricular tachycardia: a discriminant analysis

17 October 2022

90

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Determinants of survival in patients with ventricular tachyarrhythmias

17 October 2022

91

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Pharmacokinetics and pharmacodynamics of antiarrhythmic agents in patients with congestive heart failure

17 October 2022

93

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Quinidine-digoxin interaction: Time course and pharmacokinetics

17 October 2022

94

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Amiodarone increases plasma digoxin concentrations

17 October 2022

95

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Antiarrhythmic drug therapy for congestive heart failure with focus on moricizine

17 October 2022

96

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Congestive heart failure induced by six of the newer antiarrhythmic drugs

17 October 2022

97

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure

17 October 2022

98

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors

17 October 2022

99

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Clinical predictors of arrhythmia worsening by antiarrhythmic drugs

17 October 2022

100

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy

17 October 2022

101

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia

17 October 2022

102

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Perioperative and long-term results after electrophysiologically directed ventricular surgery for recurrent ventricular tachycardia

17 October 2022

104

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Subendocardial resection for ventricular tachycardia: predictors of surgical success

17 October 2022

105

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

The automatic implantable cardioverter-defibrillator: an overview

17 October 2022

106

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias

17 October 2022

107

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease

17 October 2022

108

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

Usefulness of the automatic implantable cardioverter defibrillator in improving survival of patients with severely depressed left ventricular function associated with coronary artery disease

17 October 2022

109

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

The automatic implantable cardioverter-defibrillator: results, observations, and comments

17 October 2022

110

1 reference

https://api.crossref.org/works/10.1016/0002-9149(92)91257-5

17 October 2022

Identifiers

1 reference

13 August 2017

1 reference